CSPG4 and carcinoma: The lack of prognostic associations, exclusive overexpression of pCSPG4 in benign neoplasm mainly avoiding malignant transformation (SCA), and relatively rare expression of pCSPG4 in carcinoma cell lines argued against the attribution of CSPG4 pro-malignant activity.